Free Trial
NASDAQ:ASTH

Astrana Health (ASTH) Stock Price, News & Analysis

Astrana Health logo
$30.33 +1.46 (+5.06%)
Closing price 04:00 PM Eastern
Extended Trading
$30.32 0.00 (-0.02%)
As of 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Astrana Health Stock (NASDAQ:ASTH)

Advanced

Key Stats

Today's Range
$28.74
$30.61
50-Day Range
$21.46
$31.96
52-Week Range
$21.20
$63.20
Volume
420,855 shs
Average Volume
341,213 shs
Market Capitalization
$1.70 billion
P/E Ratio
59.47
Dividend Yield
N/A
Price Target
$50.50
Consensus Rating
Hold

Company Overview

Astrana Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
80th Percentile Overall Score

ASTH MarketRank™: 

Astrana Health scored higher than 80% of companies evaluated by MarketBeat, and ranked 202nd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Astrana Health has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 5 buy ratings, 4 hold ratings, and 1 sell rating.

  • Upside Potential

    Astrana Health has a consensus price target of $50.50, representing about 68.0% upside from its current price of $30.07.

  • Amount of Analyst Coverage

    Astrana Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about Astrana Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Astrana Health are expected to grow by 22.61% in the coming year, from $1.15 to $1.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Astrana Health is 59.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.49.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Astrana Health is 59.34, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.72.

  • Price to Earnings Growth Ratio

    Astrana Health has a PEG Ratio of 0.71. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Astrana Health has a P/B Ratio of 2.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Astrana Health's valuation and earnings.
  • Percentage of Shares Shorted

    4.15% of the float of Astrana Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Astrana Health has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Astrana Health has recently increased by 0.65%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Astrana Health does not currently pay a dividend.

  • Dividend Growth

    Astrana Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.15% of the float of Astrana Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Astrana Health has a short interest ratio ("days to cover") of 4.
  • Change versus previous month

    Short interest in Astrana Health has recently increased by 0.65%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Astrana Health has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Astrana Health this week, compared to 5 articles on an average week.
  • Search Interest

    Only 3 people have searched for ASTH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Astrana Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Astrana Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.00% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Astrana Health's insider trading history.
Receive ASTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ASTH Stock News Headlines

Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
See More Headlines

ASTH Stock Analysis - Frequently Asked Questions

Astrana Health's stock was trading at $31.53 at the start of the year. Since then, ASTH shares have decreased by 4.6% and is now trading at $30.0650.

Astrana Health, Inc. (NASDAQ:ASTH) released its quarterly earnings data on Thursday, August, 7th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.36 by $0.17. Astrana Health's quarterly revenue was up 34.7% on a year-over-year basis.
Read the conference call transcript
.

Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
8/07/2025
Today
10/07/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Business Services
Current Symbol
NASDAQ:ASTH
Previous Symbol
NASDAQ:ASTH
CIK
1083446
Employees
1,900
Year Founded
N/A

Price Target and Rating

High Price Target
$66.00
Low Price Target
$36.00
Potential Upside/Downside
+66.5%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.51
Trailing P/E Ratio
59.47
Forward P/E Ratio
26.37
P/E Growth
0.71
Net Income
$43.15 million
Net Margins
1.04%
Pretax Margin
2.12%
Return on Equity
3.43%
Return on Assets
1.87%

Debt

Debt-to-Equity Ratio
0.52
Current Ratio
1.59
Quick Ratio
1.59

Sales & Book Value

Annual Sales
$2.42 billion
Price / Sales
0.70
Cash Flow
$1.57 per share
Price / Cash Flow
19.37
Book Value
$14.59 per share
Price / Book
2.08

Miscellaneous

Outstanding Shares
56,060,000
Free Float
51,317,000
Market Cap
$1.70 billion
Optionable
Optionable
Beta
0.80
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ASTH) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners